The effect of apolipoprotein E genotype on serum lipoprotein particle response to exercise

Atherosclerosis

Volumn 188, Issue 1, 2006, Pages 126-133

  Seip, Richard L ^a   Otvos, James ^b   Bilbie, Cherie ^a   Tsongalis, Gregory J ^a   Miles, Mary ^c   Zoeller, Robert ^d   Visich, Paul ^e   Gordon, Paul ^f   Angelopoulos, Theodore J ^g   Pescatello, Linda ^h,i   Moyna, Niall ^j   Thompson, Paul D ^a  

^a HARTFORD HOSPITAL   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

^d FLORIDA ATLANTIC UNIVERSITY   (United States)

^e CENTRAL MICHIGAN UNIVERSITY   (United States)

^f WEST VIRGINIA UNIVERSITY   (United States)

^g UNIVERSITY OF CENTRAL FLORIDA   (United States)

^h UNIVERSITY OF CONNECTICUT   (United States)

ⁱ BROWN UNIVERSITY   (United States)

^j DUBLIN CITY UNIVERSITY   (Ireland)

more..

Author keywords

Aerobic exercise; Apo E; Lipid metabolism; Lipoproteins; Particle size

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY MASS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEART RATE; HOMOZYGOTE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN METABOLISM; MALE; METABOLIC DISORDER; NORMAL HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SEX ROLE;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEINS E; COHORT STUDIES; EXERCISE; FEMALE; GENOTYPE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED;

EID: 33746528875     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.06.050     Document Type: Article

References (42)

1. Rosenson R.S., Otvos J.D., and Freedman D.S. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 90 (2002) 89
2. Kuller L., Arnold A., Tracy R., et al. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study. Arterioscler Thromb Vasc Biol 22 (2002) 1175
3. Blake G.J., Otvos J.D., Rifai N., and Ridker P.M. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. CIRC 106 (2002) 1930
4. Soedamah-Muthu S.S., Chang Y.F., Otvos J., Evans R.W., and Orchard T.J. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 46 (2003) 674
5. Otvos J.D. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab 48 (2002) 171
6. Williams P.T., Superko H.R., Haskell W.L., et al. Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 23 (2003) 314
7. Weisgraber K.H., Innerarity T.L., Rall Jr. S.C., and Mahley R.W. Atherogenic lipoproteins resulting from genetic defects of apolipoproteins B and E. Ann N Y Acad Sci 598 (1990) 37
8. Demant T., Bedford D., Packard C.J., and Shepherd J. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. J Clin Invest 88 (1991) 1490
9. Berneis K.K., and Krauss R.M. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 43 (2002) 1363
10. Mahley R.W., and Huang Y. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr Opin Lipidol 10 (1999) 207
11. Thuren T., Weisgraber K.H., Sisson P., and Waite M. Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins. Biochemistry 31 (1992) 2332
12. de Man F.H., de Beer F., van de L.A., Smelt A.H., Leuven J.A., and Havekes L.M. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase. Atherosclerosis 136 (1998) 255
13. Thompson P.D., Tsongalis G.J., Seip R.L., et al. Apolipoprotein E genotype and changes in serum lipids and maximal oxygen uptake with exercise training. Metabolism 53 (2004) 193
14. Dallongeville J., Lussier-Cacan S., and Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 33 (1992) 447
15. Williams P.T., Krauss R.M., Wood P.D., Lindgren F.T., Giotas C., and Vranizan K.M. Lipoprotein subfractions of runners and sedentary men. Metabolism 35 (1986) 45
16. Yu H.H., Ginsburg G.S., O'Toole M.L., Otvos J.D., Douglas P.S., and Rifai N. Acute changes in serum lipids and lipoprotein subclasses in triathletes as assessed by proton nuclear magnetic resonance spectroscopy. Arterioscler Thromb Vasc Biol 19 (1999) 1945
17. Williams P.T., Krauss R.M., Vranizan K.M., Albers J.J., Terry R.B., and Wood PD.S. Effects of exercise-induced weight loss on low density lipoprotein subfractions in healthy men. Arteriosclerosis 9 (1989) 623
18. Kraus W.E., Houmard J.A., Duscha B.D., et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347 (2002) 1483
19. Kang H.S., Gutin B., Barbeau P., et al. Physical training improves insulin resistance syndrome markers in obese adolescents. Med Sci Sports Exerc 34 (2002) 1920
20. Richard P., Thomas G., de Zulueta M.P., et al. Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA. Clin Chem 40 (1994) 24
21. Cullinane E.M., Yurgalevitch S.M., Saritelli A.L., Herbert P.N., and Thompson P.D. Variations in plasma volume affect total and low-density lipoprotein cholesterol concentrations during the menstrual cycle. Metabolism 44 (1995) 965
22. Callaway C.W., Chumlea W.C., Bouchard C., et al. Circumferences. Anthropometric standardization reference manual. Champaign, IL. Hum Kinet (1988) 39-53
23. Pollock M.L. Exercise in health and disease: evaluation and prescription for prevention and rehabilitation (2003), Saunders, Philadelphia
24. Nutrient Data System. Minneapolis, MN: University of Minnesota; 2002.
25. Lada A.T., and Rudel L.L. Associations of low density lipoprotein particle composition with atherogenicity. Curr Opin Lipidol 15 (2004) 19
26. Brown B.G., Morse J.S., Zambon A., Otvos J.D., Lanman R.B., and Krauss R.M. Frequency, importance, and conversion of large/buoyant LDL type during treatment with simvastatin plus niacin or their placebos: comparison of four methods. CIRC 108:IV-197 (2003) [abstract]
27. Kowal R.C., Herz J., Weisgraber K.H., Mahley R.W., Brown M.S., and Goldstein J.L. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem 265 (1990) 10771
28. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 113 (1987) 433
29. Rubinsztein D.C. Apolipoprotein E: a review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer's disease. Psychol Med 25 (1995) 223
30. Thompson P. What do muscles have to do with lipoproteins?. CIRC 81 (1990) 1428
31. Seip R.L., Angelopoulos T.J., and Semenkovich C.F. Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue. Am J Physiol 268 (1995) E229
32. Packard C.J., Demant T., Stewart J.P., et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 41 (2000) 305
33. Lagrost L., Gambert P., and Lallemant C. Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb 14 (1994) 1327
34. Chapman M.J., Laplaud P.M., Luc G., et al. Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res 29 (1988) 442
35. Musliner T.A., and Krauss R.M. Lipoprotein subspecies and risk of coronary disease. Clin Chem 34 (1988) 78
36. Tran Z.V., and Weltman A. Differential effects of exercise on serum lipid and lipoprotein levels seen with changes in body weight. A meta-analysis. JAMA 254 (1985) 919
37. Leon A.S., Gaskill S.E., Rice T., et al. Variability in the response of HDL cholesterol to exercise training in the HERITAGE Family Study. Int J Sports Med 23 (2002) 1
38. Nickerson D.A., Taylor S.L., Fullerton S.M., et al. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res 10 (2000) 1532
39. Stengard J.H., Clark A.G., Weiss K.M., et al. Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet 71 (2002) 501
40. Hubacek J.A., Pitha J., Adamkova V., Skodova Z., Lanska V., and Poledne R. Apolipoprotein E and apolipoprotein CI polymorphisms in the Czech population: almost complete linkage disequilibrium of the less frequent alleles of both polymorphisms. Physiol Res 52 (2003) 195
41. Stephens J.C., Schneider J.A., Tanguay D.A., et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science 293 (2001) 489-493
42. Bouchard C., and Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc 31 (2001) S446